Journey Medical regains Nasdaq compliance with stockholders' equity rule

Journey Medical Corp

Previously notified Aug 15, 2023 of non-compliance with Nasdaq minimum $2.5M stockholders' equity.
Received $19M upfront payment from license agreement on Aug 31, 2023 to address deficiency.
On Sep 20, 2023, Nasdaq Staff confirmed the company meets the Stockholders' Equity Requirement.
Company remains listed on Nasdaq Capital Market; delisting risk removed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.